News
News from us and our partners
News
Crossover
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Tags
Topics
0 results
- News
AAVantgarde announces first patient dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 study for retinitis pigmentosa related to USH1B
- News
F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US
- News
Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion
- News
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
- News
Sofinnova Partners appoints Karl Naegler as Partner
- News
AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer
- News
HEPTA Medical secures €5.7 million Series A, led by BPI France to advance minimally invasive lung cancer treatment
- News
Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas
- News
AFYREN announces signing of new commercial contract with US nutraceutical maker
- News
HighLife receives ISO 13485 certification of its quality management system
- News
Mediar Therapeutics initiates second clinical program in portfolio of novel first-in-class antibodies designed to halt fibrosis
- News
Video: Sofinnova Partners 2024 annual general meeting
- News
NodThera announces appointment of Greg Chow as Chief Financial and Business Officer
- News
Micropep raises $29m in Series B funding and unveils Krisalix, its proprietary discovery platform
- News
deepc closes Series A extension to accelerate global deployment of healthcare AI, bringing total funding to $30m